✦ LIBER ✦

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer

✍ Scribed by A. J. Wilson; M. Baum; D. M. Brinkley; J. A. Dossett; K. McPherson; J. S. Patterson; R. D. Rubens; F. G. Smiddy; B. A. Stoll; D. Richards; S. H. Ellis

Publisher: Springer
Year: 1985
Tongue: English
Weight: 751 KB
Volume: 9
Category: Article
ISSN: 0364-2313
DOI: 10.1007/bf01655191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant tamoxifen in postmenopausal bre

Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial

✍ Thierry Delozier; Jean-Pierre Julien; Paul Juret; Corinne Veyret; Jean-Etienne C 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 386 KB

Ten-year results of a randomized trial o

Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer

✍ Yoshinobu Hata; Hiromasa Takahashi; Satoru Todo; Minoru Okazaki; Kazuaki Asaishi 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 478 KB

Twelve-year mortality results of a rando

Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)

✍ Carol Alliot 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Twelve-year mortality results of a rando

Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)

✍ Maurizio Belfiglio; Miriam Valentini; Fabio Pellegrini; Giorgia De Berardis; Mon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND This study evaluated the impact on overall survival (OS) of 2 versus 5 years adjuvant tamoxifen in early breast carcinoma patients after 12 years of follow‐up. ## METHODS Women with breast carcinoma T1–3, N0–3, M0, aged 50–70 years, were eligible for this multicenter ra

Controlled trials in the treatment of “e

Controlled trials in the treatment of “early” breast cancer: A review of published results

✍ Helen J. Stewart 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 374 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b